Ambassador Animal Hospital, Ltd. v. Elanco Animal Health Incorporated

CourtDistrict Court, N.D. Illinois
DecidedFebruary 22, 2022
Docket1:20-cv-02886
StatusUnknown

This text of Ambassador Animal Hospital, Ltd. v. Elanco Animal Health Incorporated (Ambassador Animal Hospital, Ltd. v. Elanco Animal Health Incorporated) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ambassador Animal Hospital, Ltd. v. Elanco Animal Health Incorporated, (N.D. Ill. 2022).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

Ambassador Animal Hospital, Ltd., individually and as the representative of a class of similarly situated persons, Case No. 20-cv-2886

Plaintiff, Judge Mary M. Rowland v.

Elanco Animal Health, Incorporated and Eli Lilly and Company,

Defendants.

MEMORANDUM OPINION AND ORDER Plaintiff Ambassador Animal Hospital, Ltd. brings this putative class action against Elanco Animal Health, Incorporated and its former parent company, Eli Lilly and Company, for violations of the Telephone Consumer Protection Act (TCPA) and Illinois conversion law. In its original complaint, Plaintiff claimed that Defendants sent her faxes without her consent for commercial purposes. Defendants did not deny sending the faxes but maintained that the complaint failed to plausibly allege that the faxes constituted unlawful commercial advertisements. This Court agreed and granted Defendants’ motion to dismiss and allowed Plaintiff an opportunity to amend. Plaintiff timely filed an amended complaint [48], which Defendants have again moved to dismiss [51]. For the reasons explained below, this Court concludes that Plaintiff’s amended complaint fails to cure the factual deficiencies identified previously, and thus, grants Defendants’ renewed motion to dismiss [51]. I. Background This Court presumes familiarity with, and incorporates by reference, its prior opinion on Defendants’ original motion to dismiss, see Ambassador Animal Hospital,

Ltd. v. Elanco Animal Health, Inc., No. 20-CV-2886, 2021 WL 633358 (N.D. Ill. Feb. 18, 2021). The following facts come from Plaintiff’s amended complaint. Defendant Elanco provides products and services for the animal health and food-animal production industries. [48] ¶ 14. As of April 2018, Elanco was a division of Defendant Lilly; in September 2018, Lilly spun off part of its stake in Elanco, and then disposed of its other shares in 2019. Id.

Plaintiff alleges, on information and belief, that Defendants have sent thousands of advertisements via fax to targeted recipients. Id. ¶ 16. They sent two of those faxes to Plaintiff in April 2018. Id. The faxes invited veterinarians or veterinary practice owners to attend and participate in programs on topics of interest to veterinarians. Id. ¶ 18. The faxes sent to Plaintiff prominently feature the Elanco logo and say they are “Fm: Elanco Animal Health.” Id. The faxes also appear to offer a free meal and “CE Credit” in exchange for attendance. Id. ¶ 19.

Plaintiff did not expressly invite or give permission to anyone to receive these faxes. Id. ¶ 40. Plaintiff did not respond to either program invitation and did not attend any of the offered programs. Id. ¶ 21. Plaintiff alleges, on information and belief, that Elanco used the program invitations and programs to market its animal health goods and services. Id. ¶ 22. The first fax directed recipients to RSVP by calling Jim Archer, Senior District Manager at Elanco, and the second directed recipients to call either a Taylor Johnson or Elanco’s Executive Territory Manager, Nicole Cochran. Id. ¶¶ 25–26, 31–32. As it did in its original complaint, Plaintiff brings a two-count amended

complaint for violations of the TCPA (Count I) and conversion (Count II). Id. ¶¶ 54– 71, 72–79. II. Legal Standard A motion to dismiss tests the sufficiency of a counterclaim, not the merits of the case. Gunn v. Cont’l Cas. Co., 968 F.3d 802, 806 (7th Cir. 2020). To survive a motion to dismiss under Rule 12(b)(6), the counterclaim “must provide enough factual

information to state a claim to relief that is plausible on its face and raise a right to relief above the speculative level.” Haywood v. Massage Envy Franchising, LLC, 887 F.3d 329, 333 (7th Cir. 2018) (quoting Camasta v. Jos. A. Bank Clothiers, Inc., 761 F.3d 732, 736 (7th Cir. 2014)); see also Fed. R. Civ. P. 8(a)(2) (requiring a complaint to contain a “short and plain statement of the claim showing that the pleader is entitled to relief”). A court deciding a Rule 12(b)(6) motion accepts the well-pleaded factual allegations as true and draws all permissible inferences in the pleading

party’s favor. Degroot v. Client Servs., Inc., 977 F.3d 656, 659 (7th Cir. 2020). Dismissal for failure to state a claim is proper “when the allegations in a complaint, however true, could not raise a claim of entitlement to relief.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 558 (2007). Deciding the plausibility of the claim is “a context-specific task that requires the reviewing court to draw on its judicial experience and common sense.” Bilek v. Fed. Ins. Co., 8 F.4th 581, 586–87 (7th Cir. 2021) (quoting W. Bend Mut. Ins. Co. v. Schumacher, 844 F.3d 670, 676 (7th Cir. 2016)). III. Analysis

A. TCPA and the Court’s First Opinion TCPA liability rests upon showing that a defendant used a facsimile machine, computer, or other device to send to a facsimile machine an “unsolicited advertisement,” which means “any material advertising the commercial availability or quality of any property, goods, or services which is transmitted to any person without that person’s prior express invitation.” Ambassador Animal Hosp., 2021 WL

633358, at *2 (first quoting 47 U.S.C. § 227 (b)(1)(C); then quoting 47 U.S.C. § 227(a)(5)). Courts in this district determine whether a fax constitutes an unsolicited advertisement by assessing whether the “fax, on its face, constitutes an advertisement,” or alternatively, whether the “fax is a pretext to an advertisement.” Podiatry in Motion, Inc. v. Interviewing Servs. of Am., LLC, No. 20 C 3159, 2020 WL 5909063, at *2 (N.D. Ill. Oct. 5, 2020) (first citing Phillips Randolph Enters., LLC v. Adler-Weiner Rsch. Chi., Inc., 526 F. Supp. 2d 851, 853 (N.D. Ill. 2007); then quoting

James L. Orrington, II, D.D.S., P.C. v. Scion Dental, Inc., No. 17 C 884, 2019 WL 4934696, at **3, 5 (N.D. Ill. Oct. 7, 2019)), appeal dismissed sub nom. Podiatry in Motion, Inc. v. Interviewing Serv. of Am., LLC, No. 20-3157, 2021 WL 1784748 (7th Cir. Mar. 15, 2021). B. Amended TCPA Allegations

Like the first round of motion to dismiss briefing, the sole dispute as to the TCPA claim concerns whether Defendants’ faxes constitute such an “unsolicited advertisement” within the meaning of the TCPA. In its prior opinion, this Court determined that they are not. This Court held that the faxes do not constitute advertisements on their face because they mention Elanco’s name and logo but do not mention any of the company’s products or services. Ambassador Animal Hosp., 2021

WL 633358, at *3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Cortezano v. Salin Bank & Trust Co.
680 F.3d 936 (Seventh Circuit, 2012)
Patrick Camasta v. Jos. A. Bank Clothiers, Inc.
761 F.3d 732 (Seventh Circuit, 2014)
Kathy Haywood v. Massage Envy Franchising, LLC
887 F.3d 329 (Seventh Circuit, 2018)
Carlton Gunn v. Continental Casualty Company
968 F.3d 802 (Seventh Circuit, 2020)
Joseph Degroot v. Client Services, Incorporated
977 F.3d 656 (Seventh Circuit, 2020)
Christopher Bilek v. Federal Insurance Company
8 F.4th 581 (Seventh Circuit, 2021)
West Bend Mutual Insurance Co. v. Schumacher
844 F.3d 670 (Seventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Ambassador Animal Hospital, Ltd. v. Elanco Animal Health Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ambassador-animal-hospital-ltd-v-elanco-animal-health-incorporated-ilnd-2022.